The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase II study of atorvastatin in combination with radiotherapy and temozolomide in patients with glioblastoma.
Abdullah Khalaf Altwairgi
No relevant relationships to disclose
Waleed Ali Alghareeb
No relevant relationships to disclose
Fouad H AlNajjar
No relevant relationships to disclose
Mohammed Mubasher
No relevant relationships to disclose
Hussain Alhussain
No relevant relationships to disclose
Rasha Mustafa Saleh
No relevant relationships to disclose